Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Amortizatization of Intangibles came in at $27000.0 in Q4 2025, down 63.51% YoY from $74000.0 in Q4 2024, and up 125.0% on a QoQ basis from $12000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Amortizatization of Intangibles data on file, last reported at $27000.0 in Q4 2025.
- Quarterly Amortizatization of Intangibles fell 63.51% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65000.0 (down 52.9% YoY) and the FY2025 annual result came in at $65000.0, down 52.9% from the prior year.
- Amortizatization of Intangibles climbed to $27000.0 in Q4 2025, from $12000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $74000.0 in Q4 2024 to a low of $1000.0 in Q4 2021.
- A 5-year average of $17937.5 and a median of $15000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 1900.0% — and 2025, when it slumped 63.51%.
- Tracing FENC's Amortizatization of Intangibles over 5 years: stood at $1000.0 in 2021, then surged by 1400.0% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then soared by 393.33% to $74000.0 in 2024, then tumbled by 63.51% to $27000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $27000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |